Skip to content
‹ Back to IndustriesHealthcare

Harnessing the Power of UV Light for Virus Protection

The world is currently facing a probable epidemic related to the coronavirus. According to the Centers for Disease Control and Prevention (CDC), coronavirus (COVID-19) spreads just as other viruses do from person-to-person, mostly through respiratory droplets that occur when an infected individual sneezes or coughs. The world is on hyper-alert for ways to mitigate its spread, and…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

The world is currently facing a probable epidemic related to the coronavirus. According to the Centers for Disease Control and Prevention (CDC), coronavirus (COVID-19) spreads just as other viruses do from person-to-person, mostly through respiratory droplets that occur when an infected individual sneezes or coughs.

The world is on hyper-alert for ways to mitigate its spread, and one proven way to destroy viruses is via ultraviolet (UV) light, which may be a good option for a variety of scenarios.

UV Light Is an Effective Tool to Stop the Spread of Viruses

Much research has been completed on destroying viruses and germs. A certain spectrum of UV light—UVC—has been proven to kill airborne viruses, and it does so in a manner that presents no risk to humans. UVC refers to ultraviolet light with wavelengths between 200 – 280 nanometers (nm). A study conducted by a group of scientists found that UVC had the ability to kill flu viruses when placed in germ-sensitive places like hospitals, airports and schools.

While the coronavirus is different than the flu, it’s similar in nature. UVC is stealthy enough to destroy viruses.

The CDC also sponsored a study about the impact of UVC by using it in hospital patient rooms. The conclusions drawn from the researchers’ data confirmed that UVC-emitting devices could decrease the “bioburden of important pathogens in real-world settings.”

Introducing UV Light into HVAC Airflow and Ventilation Systems

Each day, you and your family venture out into the public domain and have a high probability of encountering germs and viruses. You probably already practice good hygiene to reduce these chances, such as thorough handwashing or use of hand sanitizer, but the threat remains.

Being able to harness the power of UVC light can make all the difference in stopping the spread and multiplication of these germs and viruses.

By introducing UV light into your airflow and ventilation systems, you’ll be better prepared to protect yourself from them.

Leveraging UV Light into Your Spaces with Field Controls

Integrating UV light into your home doesn’t require scientific expertise or a huge investment.

The Field Controls UV-Aire UV-16 unit has been designed to emit strong UVC band light through your heating or air conditioning system, sterilizing and reducing airborne microorganisms. It works to neutralize the organism’s DNA so that it can no longer replicate. As new indoor air circulates through your system, it’s being passed through the UV light, effectively treating it.

Field Controls completed multiple independent lab tests to verify its effect on viruses and germs, finding that it reduced test bacteria by 90% within 30 minutes. While the technology is highly advanced, it’s extremely simple to install. They require minimal maintenance, and you don’t need extensive training to use the products in your home.

Experience Added Protection with the UV-Aire UV-16

Doing all you can to safeguard from the coronavirus and other airborne pathogens is vital, and you can effectively do so with the UV-Aire UV-16.

Learn more about how it works and how it can deliver a healthier space today.

—

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Advocate Health's Hugh Chatham draws 65 applicants for 12 surgical tech seats

Advocate Health's Hugh Chatham draws 65 applicants for 12 surgical tech seats

Hugh Chatham Health and Alleghany Health marked one year inside Advocate Health with a surgical technology program that drew 65 applicants for 12 seats. Year one also brought $11.3 million in pay and rewards, $19.3 million in capital and nearly 1,000 specialty transfers. Local training seats look like the next limit in Elkin.

  • 01In rural North Carolina, a new surgical technology program drew more than five applicants per seat, which points to training capacity, not interest, as the thing to expand.
  • 02Pay spending in the first year of a rural affiliation came to roughly 58% of the capital figure: $11.3 million in total rewards next to $19.3 million in capital.
  • 03Transfers outnumbered virtual specialty consults about 14 to 1 in year one, so the planned growth in virtual care is the year-two number worth tracking.

Nov 10, 2026

AI cuts cardiologists' echocardiogram review time by 46%

AI cuts cardiologists' echocardiogram review time by 46%

Late-breaking research presented November 9 at the American Heart Association's Scientific Sessions 2026 reported that AI-drafted preliminary echocardiogram reports were comparable to human drafts. Cardiologists averaged 4.6 minutes finalizing AI drafts versus 8.5 minutes without AI. The findings are a non-peer-reviewed abstract.

  • 01Cardiologists averaged 4.6 minutes finalizing AI-drafted echo reports versus 8.5 minutes without AI, about 46% less time.
  • 02Cardiologists made substantial changes to 50.6% of AI drafts and 49.7% of human drafts.
  • 03The research used 1,200 echocardiograms from 21 Kaiser Permanente Northern California medical centers.

Nov 9, 2026

After Chicago: Did AI at AHA 2026 Pass Its Own Test?

After Chicago: Did AI at AHA 2026 Pass Its Own Test?

At AHA Scientific Sessions 2026 in Chicago, AI ECHO INSIGHT, WATCH-LV, PARAMOUNT and PROVAR+ showed gains in workflow efficiency, screening and treatment decisions, but none established a reduction in hard clinical events. The takeaway: the next test is proving these tools improve outcomes, especially in high-need populations, by connecting to established care.

  • 01AI ECHO INSIGHT cut echo reads 8.5 to 4.6 minutes, and PARAMOUNT changed treatment decisions, but no AI late-breaker showed fewer hard events.
  • 02ZEUS and Lp(a)HORIZON lowered their target biomarkers without reducing major cardiovascular events, a caution against treating algorithmic accuracy alone as proof of patient benefit.
  • 03Low-technology, team-based interventions such as CATCH in Colombia and Jamaica lowered blood pressure, showing the care systems AI tools must connect to.

Nov 9, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512